rrg001
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Nov 24, 2023 (NCT06141460)
Timeline
2020s
- Jan 1, 2023
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Tree pollenImmunity, desensitized
Tree pollen immunity, desensitized
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06412224 | Early Phase 1 (Phase 1) | Dec 20, 2023 | Refreshgene, Tianjin Medical University |
| NCT06141460 | Phase 1/Phase 2 (Phase 2) | Nov 24, 2023 | Refreshgene |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Refreshgene | For profit | 2 | 1 | 2 | 2023 |
| Tianjin Medical University | Academic/Hospital | 1 | 1 | 1 | 2023 |
2 organizations
Page 1 / 1